See also this year's filing and all EDGAR filings for this company.
PDF Report 0001173313_2018_ABVC_Biopharma_INC.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | Excluding company: variable exceeds outlier threshold | pre-agg | {'variable': 'Liabilities', 'value': 5845691, 'size_variable': 'Assets', 'size_value': 96273, 'ratio': 60.7, 'threshold': 20} |
Graph
Absolute values for 0001173313, ABVC Biopharma INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 2,754,851 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 0 |
| 3 | remainder_Assets | 0 |
| 4 | LiabilitiesCurrent | 0 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 4,147,914 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 707,142 |
| 9 | ResearchAndDevelopmentExpense | 3,151,162 |
| 10 | remainder_Expenses | 138,868 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | -74,811 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 2,754,851 |
| 1 | Liabilities | 4,147,914 |
| 2 | Expenses | 3,997,172 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | -1,393,063 |
| 5 | NetIncome | -4,071,983 |
| 6 | ComprehensiveNetIncome | -4,071,983 |
| 7 | BaseVar | 5,487,374 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | -2.06 |
| 9 | EconomicCapitalRatio | 1.00 |
Edgar->Model Mapping
Feature Distribution
